NewsBenzingaHC Wainwright & Co. Reiterates Buy on Tvardi Therapeutics, Maintains $9 Price Target HC Wainwright & Co. Reiterates Buy on Tvardi Therapeutics, Maintains $9 Price Target Benzinga 2026.11.20 11:22 (GMT+0) Open on Benzinga Other news BitFuFu Q3 EPS $0.14 Beats $0.03 Estimate, Sales $37.700M Miss $42.700M Estimate Symbotic Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call HC Wainwright & Co. Maintains Buy on Celldex Therapeutics, Lowers Price Target to $58 Yemeni Houthis Rebels Say That All Saudi Arabian Red Sea Ports Including Jeddah Will Be Targeted If The Coalition Strikes Yemen’s Hodeidah Port HC Wainwright & Co. Reiterates Buy on Pyxis Oncology, Maintains $8 Price Target 'Andhra govt to tap nuclear power through SMR tech as alternative to thermal power' - Press Trust Of India
Symbotic Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Yemeni Houthis Rebels Say That All Saudi Arabian Red Sea Ports Including Jeddah Will Be Targeted If The Coalition Strikes Yemen’s Hodeidah Port
'Andhra govt to tap nuclear power through SMR tech as alternative to thermal power' - Press Trust Of India